Supplementary Figure 5: IL-33 mutants exhibit more rapid release during necrosis. (A)
TE-7 cells were transiently transfected with plasmid encoding the indicated GFP-fusion protein and then treated with Triton X-100 (0.13%) to induce necrosis. Depicted are images from a representative experiment showing 5 seconds prior to cell death by the Triton X-100 ("Pre-Cell Death"; top row) and 15, 60, and 120 seconds after death ("Post-Cell Death"; second, third, and fourth rows, respectively). Scale bar is 10 μm. (B) Quantification of intracellular fluorescence intensity from two combined independent experiments. Data are normalized to time zero, which is when Triton X-100 was added. For each depicted curve, the central, thicker line indicates the mean and the bordering, thinner lines of the same color indicate the standard error of the mean. GFP, green fluorescent protein; IL, interleukin.
Supplementary Figure 6: Further characterization of acid-purified histones. (A)
DNA concentration in TE-7 cell lysates and acid-purified histones as determined by Qubit. (B) Acidextracted histones and recombinant WT IL-33-GST were incubated together in the presence of DNAse and then co-immunoprecipitated with anti-histone H2B and anti-histone H2A antibodies (αhistones) or isotype controls (IgG). Expression of GST was then assessed by Western blot analysis. (C) IL-8 levels in supernatants of HMC-1 mast cells treated overnight with 11.7 nM recombinant WT IL-33 or vehicle and indicated amounts (in µg/mL) of acid-purified histones. (D) IL-8 levels in supernants of HMC-1 mast cells treated overnight with 11.7 nM recombinant WT IL-33, 6.7 µg/mL purified acid-extracted histones, or 6.7 µg/mL recombinant histones as indicated. C and D depict mean ± standard error of the mean of data that is either representative of two experiments (C) or combined from two independent experiments. GST, glutathione Stransferase; Ig, immunoglobulin; IL-33, interleukin; ST2, suppressor of tumorigenicity 2; WT, wild-type. Table indicates fold-change of expression of indicated proteins in supernatants of cells given indicated treatments as compared to untreated cells in samples from Multiplex in Figure 8B . IL, interleukin.
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